MedTrace Logo

Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients

NCT03648151 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-07-23

No results posted yet for this study

Summary

Radiomics is an attractive field in objectively quantifying image features, and may overcome the subjectivity of visually interpreting computed tomography (CT), or positron emission tomography (PET). It is reported that the features related to treatment response, outcomes, tumor staging, tissue identification, and cancer genetics. Therefore, the investigators try to explore the key features for the outcome of lung cancer patients.

Conditions

Sponsors & Collaborators

  • The First Affiliated Hospital of Anhui Medical University

    collaborator OTHER

  • The First Affiliated Hospital of Shanxi Medical University

    lead OTHER

Principal Investigators

  • Li Sijin, MD · First Affiliated Hospital of Shanxi Medical University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03648151 on ClinicalTrials.gov